SE0301436D0 - New proteins - Google Patents

New proteins

Info

Publication number
SE0301436D0
SE0301436D0 SE0301436A SE0301436A SE0301436D0 SE 0301436 D0 SE0301436 D0 SE 0301436D0 SE 0301436 A SE0301436 A SE 0301436A SE 0301436 A SE0301436 A SE 0301436A SE 0301436 D0 SE0301436 D0 SE 0301436D0
Authority
SE
Sweden
Prior art keywords
relates
proteins
methods
new proteins
mycoides
Prior art date
Application number
SE0301436A
Other languages
Swedish (sv)
Inventor
Joakim Westberg
Anja Persson
Mathias Uhlen
Karl-Erik Johansson
Original Assignee
Joakim Westberg
Anja Persson
Mathias Uhlen
Karl-Erik Johansson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Joakim Westberg, Anja Persson, Mathias Uhlen, Karl-Erik Johansson filed Critical Joakim Westberg
Priority to SE0301436A priority Critical patent/SE0301436D0/en
Publication of SE0301436D0 publication Critical patent/SE0301436D0/en
Priority to PCT/SE2004/000753 priority patent/WO2004101795A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/30—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycoplasmatales, e.g. Pleuropneumonia-like organisms [PPLO]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The invention relates to novel protein and nucleic acid sequences of variable surface proteins of Mycoplasma mycoides subsp. mycoides biotype small colony which causes Contagious bovine pleuropneumonia. In addition the invention relates to vaccine compositions comprising the proteins of the invention and methods for de-tecting the presence of the bacterium in diagnostic and epidemiological methods.
SE0301436A 2003-05-16 2003-05-16 New proteins SE0301436D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
SE0301436A SE0301436D0 (en) 2003-05-16 2003-05-16 New proteins
PCT/SE2004/000753 WO2004101795A1 (en) 2003-05-16 2004-05-14 Variable proteins of mycoplasma mycoides, vaccines and process thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0301436A SE0301436D0 (en) 2003-05-16 2003-05-16 New proteins

Publications (1)

Publication Number Publication Date
SE0301436D0 true SE0301436D0 (en) 2003-05-16

Family

ID=20291325

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0301436A SE0301436D0 (en) 2003-05-16 2003-05-16 New proteins

Country Status (2)

Country Link
SE (1) SE0301436D0 (en)
WO (1) WO2004101795A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070009545A1 (en) * 2005-07-07 2007-01-11 Joachim Frey Mycoplasma subunit vaccine
CN101721694B (en) * 2009-11-07 2013-01-30 中国农业科学院兰州兽医研究所 Hircine primary atypical pneumonia combined inactivated vaccine and preparation method thereof
US20190030153A1 (en) * 2015-07-22 2019-01-31 University Of Saskatchewan Mycoplasma vaccines and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002542815A (en) * 1999-05-04 2002-12-17 ワーラル、エリック・エドワード Preservation method of virus and mycoplasma
WO2001040471A1 (en) * 1999-11-29 2001-06-07 Akzo Nobel N.V. Antigenic protein lppq of mycoplasma mycoidessubsp.(mycoides)sc., its preparation and use
GB0110851D0 (en) * 2001-05-03 2001-06-27 Mini Agriculture & Fisheries Vaccine
EP1521592A2 (en) * 2001-07-02 2005-04-13 Pfizer Products Inc. Mycoplasma hyopneumoniae vaccine and methods for reducing mycoplasma bovis pneumonia in cattle
US20030147914A1 (en) * 2001-07-02 2003-08-07 Pfizer Inc. Mycoplasma bovis vaccine and methods of reducing pneumonia in animals

Also Published As

Publication number Publication date
WO2004101795A1 (en) 2004-11-25

Similar Documents

Publication Publication Date Title
Zurita et al. A pertussis outer membrane vesicle-based vaccine induces lung-resident memory CD4 T cells and protection against Bordetella pertussis, including pertactin deficient strains
Murray The lipoprotein LipL32, an enigma of leptospiral biology
Rizzi et al. Vaccination with a BCG strain overexpressing Ag85B protects cattle against Mycobacterium bovis challenge
EA201890355A1 (en) NEW METHODS OF IMMUNE RESPONSE INDUCTION
ATE470673T1 (en) VACCINES CONTAINING LAWSONIAINTRACELLULAR SUBUNIT
ATE426412T1 (en) ADJUVANT INFLUENZA VACCINE
BRPI0520330B8 (en) polynosinic-polycytidyl acid-based adjuvant
DK1185691T3 (en) Genomic neonatal sequences and methods for their use
MX2007003402A (en) Immunogenic composition for use in vaccination against staphylococcei.
DK1487485T3 (en) Imidazoquinoline adjuvants for DNA vaccines
NO20063254L (en) Immunostimulatory composition comprising at least one toll-like receptor 7 or toll-like receptor 8 agonist and one toll-like receptor 4 agonist
EA200870129A1 (en) HUMAN ANTIBODIES AGAINST IL-23, COMPOSITIONS, METHODS AND APPLICATIONS
CY1107950T1 (en) NAVIGATION VACCINE COMPOSITIONS AND METHODS
DE60120621D1 (en) Lawsonia intracellular vaccine
ME00982B (en) Attenuated mycoplasma gallisepticum strains
RS51402B (en) Immunostimulatory combinaton for the prophylactics and treatment of hepatitis c
UA103885C2 (en) Immunogenic streptococcus proteins
SE0301436D0 (en) New proteins
Kim et al. Protective vaccine efficacy of the complete form of PPE39 protein from Mycobacterium tuberculosis Beijing/K strain in mice
DE602004024423D1 (en) VACCINE WITH LAWSONIA INTRACELLULARIS SUB-UNIT
CY1105947T1 (en) MYCOPLASMA HYOPNEUMONIAE MHP3 GENE NUCLEIC ACIDS AND PROTEINS AND USES THEREOF
BR0208786A (en) Method for identification of intracellular bacterial proteins
Vordermeier et al. Development of cattle TB vaccines in the UK
ATE420658T1 (en) IMIDAZOQUINOLINAMINE AS ADJUVANTS FOR HIV DNA VACCINES
BRPI0604365A (en) isolated polypeptide, multi-tick vaccine composition, and use thereof